Clinical Trial Update: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for T3011 administered intratumorally in advanced solid tumors, including phase 1 and phase 2 cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Esophageal Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-melanoma Skin Cancer
• Non-small Cell Lung Cancer
• Sarcoma
• Solid Tumor

Drugs mentioned

• T3011

Snippet

Sponsor: ImmVira Pharma Co. Ltd | Conditions: Advanced Solid Tumor, Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN